The U.S. National Institutes of Health has granted Israel’s Pluri (previously Pluristem) $4.2 million to develop its PLX-R18 (see here) as a treatment for Hematopoietic Acute Radiation Syndrome – a deadly disease that can result from nuclear disasters and radiation … Continue reading →

I reported previously (see here) on the PLX-R18 stem cell treatment for radiation sickness from Israel’s Pluristem. Animal trials by the US Department of Defense demonstrated that PLX-R18, administered before and after radiation exposure increased survival rates by 46-70%. https://www.jpost.com/HEALTH-SCIENCE/Pluristem-gets-positive-results-from-radiation-treatment-trials-597271

I reported previously (see here) on the stem cell treatment of Israel’s Pluristem for radiation sickness. Pluristem’s four-year studies show that its placenta-based PLX-R18 cells are effective as a treatment for radiation damage to the gastrointestinal tract and bone marrow. … Continue reading →

I previously reported (here) on the therapy from Israel’s Pluristem for treating patients exposed to lethal radiation doses. Pluristem is to join the US National Institute of Allergy and Infectious Diseases program designed to protect people from catastrophic incidents. http://www.jpost.com/Israel-News/US-government-to-stocking-Israeli-bio-tech-cure-to-lethal-radiation-in-2017-445620

Japan’s Fukushima Medical University and Israel’s Pluristem Therapeutics are to develop Pluristem’s PLX-R18 cells to treat acute radiation syndrome (ARS). Radiation continues to spread following the Fukushima nuclear plant disaster. http://www.timesofisrael.com/japan-turns-to-israeli-tech-to-treat-radiation-disease/

Stem cells from Israel’s Pluristem have been used in clinical tests to successfully treat bone marrow failure following total body exposure to high doses of radiation. http://www.timesofisrael.com/israeli-radiation-disease-treatment-passes-major-hurdle/ http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0066549

Israeli biotech Pluristem Therapeutics has announced that initial animal studies found that its placental stem cells can treat Acute Radiation Syndrome (ARS). http://www.globes.co.il/serveen/globes/docview.asp?did=1000680388&fid=1725